Dextran and its potential use as tablet excipient

Luca Casettari, Giulia Bonacucina, Gordon A. Morris, Diego R. Perinelli, Paolo Lucaioli, Marco Cespi, Giovanni Filippo Palmieri

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)


Dextrans are a class of carbohydrate polymers extensively applied in pharmaceutical applications, particularly as drug conjugate macromolecular carriers or drug delivery systems. These polysaccharides improve the stability of the therapeutics enabling also the control of their release, via either the parenteral and or oral routes. In the latter case, due to their gel forming ability they may have potential as hydrophilic matrix tablets for sustained drug release.In this paper, we investigated the behaviour of different molecular weight (1, 40, 500 and 2300. kDa) dextrans as tabletting excipients. Powder particle size and hygroscopic studies have been reported, together with tabletability, tablet stability and tablet swelling. Moreover we use tramadol as model compound to evaluate the ability of dextrans to control drug dissolution. The results suggest that dextrans with lower molecular weights may be a promising excipient to be used as filler for immediate release tablets, due to their good tabletability and fast dissolution rate, while dextrans with higher molecular weights could be an efficient disintegrant due to their swelling ability.

Original languageEnglish
Pages (from-to)125-132
Number of pages8
JournalPowder Technology
Early online date19 Dec 2014
Publication statusPublished - 1 Mar 2015


Dive into the research topics of 'Dextran and its potential use as tablet excipient'. Together they form a unique fingerprint.

Cite this